Neuropsychiatric Effects of HIV Antiviral Medications

@article{Treisman2016NeuropsychiatricEO,
  title={Neuropsychiatric Effects of HIV Antiviral Medications},
  author={G. Treisman and Olivia Soudry},
  journal={Drug Safety},
  year={2016},
  volume={39},
  pages={945-957}
}
  • G. Treisman, Olivia Soudry
  • Published 2016
  • Medicine
  • Drug Safety
  • The development of antiretroviral therapy (ART) has dramatically increased the lifespan of HIV patients but treatment is complicated by numerous adverse effects and toxicities. ART complications include neuropsychiatric, metabolic, gastrointestinal, cardiac, and numerous other toxicities, and clinicians often have to choose one toxicity over another to offer the best medication regimen for a patient. Some antiviral drugs cause significant neuropsychiatric complications, including depression… CONTINUE READING
    22 Citations
    CNS Neurotoxicity of Antiretrovirals
    • 1
    Inflammatory Mechanisms and Cascades Contributing to Neurocognitive Impairment in HIV/AIDS.
    • 3
    Human Immunodeficiency Virus and the Nervous System.
    • 2
    Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals
    • 13
    Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response
    • 14
    The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites
    • 3
    SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV
    • 6

    References

    SHOWING 1-10 OF 135 REFERENCES
    Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.
    • 13
    Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
    • 192
    Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
    • 76
    Mood disorders in HIV infection
    • 4
    Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms
    • 44